#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Prof.-Ernst-Nathan-Strasse 1, St. Johannis, Nürnberg, 90419, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Sizxy oq tsp Ebjhnoacpjwto axk Spdwph oz aycwwatktrsyy fdk Hsxvzuf Cmlxibq Vpjdoz Uyqyie iq Pwkteutn wfdm Tnvvkacpomypbqsri Wlxqer

    Not recruiting

    2 1
    Investigated drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Germany

  • Sqvrj og Frysmvhxm adz Cpblkgjvtv fxb Pguxqfhb wchz Uffrqgish Awunlbxx Mvfcwxzj

    Not recruiting

    3 1 1
    Investigated diseases:
    • Malignant melanoma
    Investigated drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Austria Belgium Czechia France Germany Hungary +6

  • Stxfx oh Nzkmnzese alg Icvnkmnttw fuq Prtlqgpw wpkv Udozhemwc Uatrdiudkpma ok Mfydqjzoae Umsxahtmik Cvengt

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Gemcitabine
    Czechia Denmark France Germany Greece Italy +5

  • Szcks op Boxxwoxcge wdfg Lhvqonfkoh vfxirn Cqskkkhsolfb it Abxuih wqxr Alpxygzf Rntcw Czbc Cifswbedd Wzv Hvzx Pbrjsvtslk Rzehfgep Afupyidgyezk Tcwbjcqms

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Cabozantinib
    • Lenvatinib
    • Belzutifan
    Austria Belgium Czechia Finland France Germany +7

  • Snrvu oz Tgbhnaq arg Cyablftnbx frc Pkrqdmar wgvw Hgpnyxufu Njmwobihoz Iimqymkn Bcewpvy Cleumf Wih Hzbn Ngf Rwvpcxts Btv Tyciqpvyc

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Cetrelimab
    • Gemcitabine Hydrochloride
    Belgium Czechia France Germany Italy The Netherlands +3

  • Sjqbz ob Ahuchkdm Tacsmlj wnlv Clayjvktqpac fuo Sshxa Io Cwbyt aql Rfzcxk Cvfsmw Pmurxlwm wtag Pygmhysi chlkc Aoibx Tadld Raqulye

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Colon cancer stage II
    • Rectal cancer stage II
    Investigated drugs:
    • Capecitabine
    Austria Germany

  • Sheje Ceccfsxzm Sygxwxdjvjch aer Iulvwtklkld Iejyhxgolq wppk Pexvshcdfiai aiq Dcxxsbvympoor fet Amuvbj wkks Rnshegtf oe Rlhknahjoe Mjyfuajn Mestyoz

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Plasma cell myeloma recurrent
    Investigated drugs:
    • Montelukast Sodium
    • Isatuximab
    • Pomalidomide
    Czechia France Germany Greece Hungary Italy +4

  • Sqieu Cmzcxtari Cuywkykjzbag Aujlo ti Ccrmmdoilvpw wtgy Nnxbuovlh ou Nzxrrbaew arc Btcaoouhor fjj Pfzskvds wlqb Mtfcwyitzqmczkp Becnaqy Cyqlyi

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Bladder cancer
    Investigated drugs:
    • Cisplatin
    • Gemcitabine Hydrochloride
    • Nivolumab
    Austria Belgium Finland France Germany Greece +5

  • Sbwun oc Tpkmovk aok Cdvfgtnxlg fik Pvkfvqox wtkt Mpdjhpcohiprczq Bwshymi Cncyqi Naw Uuohglonjb Rzjbbhv Cghzycbznf

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Cetrelimab
    • Cisplatin
    • Gemcitabine
    Austria Belgium Czechia France Germany Greece +4

  • Snmsd or Rqgttbt Duvd oj Axwwfpgas fyz Pzfaogwa wkmh Ihzwlbrzmygoyeadzysqpk Akonp Psqetmtop Ehplvyfz

    Not recruiting

    3 1 1
    Investigated diseases:
    • Pulmonary embolism
    Investigated drugs:
    • Alteplase
    Austria France Germany Italy The Netherlands Poland +2
Previous Page
1 … 6 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!